KW 5092

Drug Profile

KW 5092

Latest Information Update: 16 Oct 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kyowa Hakko
  • Class Gastrokinetics; Imidazoles; Neuroprotectants; Nitriles; Small molecules
  • Mechanism of Action Acetylcholinesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gastro-oesophageal reflux

Most Recent Events

  • 18 Jul 2000 Discontinued - Phase-II for Gastro-oesophageal reflux in Japan (unspecified route)
  • 12 Oct 1999 A study has been added to the pharmacodynamics section
  • 12 Apr 1996 Phase-I clinical trials for Gastro-oesophageal reflux in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top